GPC3 and hepatocellular carcinoma: To date, as a non-invasive biomarker in the diagnosis of HCC, clinicians use α-fetoprotein (AFP) most frequently; des-gamma-carboxy prothrombin (DCP) and glypican-3 (GPC3) also serve as non-invasive biomarkers.